Hereditary Malignant Neoplasm — Trials

Hereditary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 14
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03943173	Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery	active not recruiting	Early Phase 1	15	M.D. Anderson Cancer CenterOTHER	1	Aug 12, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials